Leiomyosarcoma of the maxilla: Effective chemotherapy with docetaxel (DOC) and cisplatin (CDDP) using superselective intra-arterial infusion via superficial temporal artery

Oral Oncology Extra

Volumn 42, Issue 7, 2006, Pages 258-262

  Mitsudo, Kenji ^a   Tohnai, Iwai ^b   Fujimoto, Yasushi ^a   Sawaki, Yoshihiro ^c   Sugimura, Tomotaka ^a   Nishiguchi, Hiroaki ^a   Fukui, Takafumi ^a   Yamoto, Noriyuki ^a   Ueda, Minoru ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c Nakatsugawa Municipal General Hospital   (Japan)

Author keywords

Cisplatin; Docetaxel; Leiomyosarcoma; Maxilla; Superselective intra arterial chemotherapy

Indexed keywords

EID: 33746862913     PISSN: 17419409     EISSN: 17419409     Source Type: Journal    
DOI: 10.1016/j.ooe.2006.05.001     Document Type: Article

References (18)

1. Som P.M., and Brandwein M. Sinonasal cavities: inflammatory disease, tumor, fractures and postoperative findings. In: Som P.M., and Curtin H.D. (Eds). Head and neck imaging. 3rd ed. (1996), Hea, St. Louis 126-318
2. Tokiya R., Imajo Y., Yoden E., et al. A long-term survivor of leiomyosarcoma around the right side of the base of the skull: effective radiotherapy combined with intra-arterial chemotherapy. Int J Clin Oncol 7 (2002) 57-61
3. Muzio L.L., Favia G., Mignogna M.D., Piattelli A., and Mariorano E. Primary intraoral leiomyosarcoma of the tongue: an immunohistochemical study and review of the literature. Oral Oncol 36 (2000) 519-524
4. Tohnai I., Fuwa N., Hayashi Y., Kaneko R., Tomaru Y., Hibino Y., et al. New superselective intra-arterial infusion via superficial temporal artery for cancer of the tongue and tumor tissue platinum concentration after carboplatin (CBDCA) infusion. Oral Oncol 34 (1998) 387-390
5. Dry S.M., Jorgensen J.L., and Fletcher C.D.M. Leiomyosarcomas of the oral cavity: An unusual topographic subset easily mistaken for nonmesenchymal tumors. Histopathol 36 (2000) 210-220
6. Vilos G.A., Rapidis D., Lagogiannis G.D., Lagogiannis G.D., and Apostolidis C. Leiomyosarcomas of the oral Tissues: clinicopathologic analysis of 50 cases. J Oral Maxillofac Surg 63 (2005) 1461-1477
7. Thigpen J.T., Blessing J.A., Beecham J., Homesley H., and Yorden E. Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a gynecologic oncology group study. J Clin Oncol 9 (1991) 1962-1966
8. Sutton G.P., Blessing J.A., and Malfetano J.H. Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a gynecologic oncology group study. Gynecol Oncol 62 (1996) 226-229
9. Gallup D.G., Blessing J.A., Andersen W., and Morgan M.A. Evaluation of paclitaxel in previously treated leiomyosarcoma of the uterus: a gynecologic oncology group study. Gynecol Oncol 89 (2003) 48-51
10. Sutton G.P., Blessing J.A., Hanjani P., and Kramer P. Phase II evaluation of liposomal doxorubicin (Doxil) in recurrent or advanced leiomyosarcoma of the uterus: a gynecologic oncology group study. Gynecol Oncol 96 (2004) 749-752
11. Look K.Y., Sandler A., Blessing J.A., Lucci III J.A., and Rose P.G. Phase II trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma: a gynecologic oncology group (GOG) study. Gynecol Oncol 92 (2004) 644-647
12. Hensley M.L., Maki R., Venkatraman E., Geeler G., Lovegren M., Aghajanian C., et al. Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J Clin Oncol 20 12 (2002) 2824-2831
13. Robbins K.T., Storniolo A.M., Kerber C., Vicario D., Seagren S., Shea M., et al. Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancer. J Clin Oncol 12 (1994) 2113-2120
14. Fuwa N., Ito Y., Matsumoto A., et al. A combination therapy of continuous superselective intraarterial carboplatin infusion and radiation therapy for locally advanced head and neck carcinoma. Phase I study Cancer 89 (2000) 2099-2105
15. Furutani K., Fuwa N., Kodaira T., Matsumoto A., Kamata M., Tachibana H., et al. Continuous selective intraarterial chemotherapy in combination with irradiation for locally advanced cancer of the tongue and tongue base. Oral Oncol 38 (2002) 145-152
16. Kitagawa Y., Nishizawa S., Sano K., et al. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma. J Nucl Med 44 (2003) 198-206
17. Nakasato T., Katoh K., Sone M., et al. Superselective continuous arterial infusion chemotherapy through the superficial temporal artery for oral cavity tumors. Am J Neuroradiol Roentgenol 21 (2000) 1917-1922
18. Tohnai I., Fuwa K., Mitsudo K., et al. Daily concurrent preoperative chemoradiotherapy with docetaxel (D) and cisplatin (C) using new superselective intra-arterial infusion via superficial temporal artery (HFT method) for stage III, IV head and neck cancer. Proc ASCO (2005) 22